Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CGEN
CGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CGEN News
Compugen Reports 2025 Financial Results and Strategic Update
Mar 02 2026
PRnewswire
Compugen Q4 Earnings Exceed Expectations with Significant Revenue Growth
Mar 02 2026
seekingalpha
Compugen Set to Announce Q4 Earnings on March 2nd
Feb 27 2026
seekingalpha
Compugen to Participate in Upcoming Investor Conferences
Feb 19 2026
PRnewswire
Compugen to Release Q4 and Full Year 2025 Financial Results
Feb 17 2026
PRnewswire
Compugen Appoints New Independent Director
Feb 12 2026
PRnewswire
HC Wainwright Initiates Buy on Jade Biosciences with $25 Price Target
Jan 07 2026
Benzinga
Compugen Agrees with AstraZeneca to Monetize Future Royalties of Rilvegostomig
Dec 17 2025
PRnewswire
Compugen Secures $65 Million Upfront Payment in AstraZeneca Deal
Dec 17 2025
Newsfilter
Compugen's Stock Increases Following Royalty Agreement with AstraZeneca
Dec 17 2025
SeekingAlpha
Compugen Reports Third Quarter 2025 Results
Nov 10 2025
PRnewswire
Compugen to Participate in Stifel 2025 Healthcare Conference
Nov 04 2025
PRnewswire
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
Oct 27 2025
PRnewswire
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Oct 13 2025
PRnewswire
Compugen to Present Research at the Single Cell Genomics 2025 Conference
Sep 08 2025
PRnewswire
Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 28 2025
PRnewswire
Show More News
